Clinical trial
Alternate Day Buprenorphine Administration, Phase IX
NCT00000232 is registered in ClinicalTrials.gov with University of Vermont as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Alternate Day Buprenorphine Administration, Phase IX
- Lead sponsor
- University of Vermont
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 31, 1992
- Completion date
- Not reported
- Enrollment
- 0
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.